Heterozygous familial hypercholesterolemia

There are 46 papers on heterozygous familial hypercholesterolemia in aging research: 12 trials and 12 observational studies in people, 19 reviews.

Disease

46 papers study it8 more mention it6 findings

22 new papers in 30 daysSee all 54 papers on heterozygous familial hypercholesterolemia

“Normal coronary arteries were found in 161 (37.0%) patients, non-obstructive CAD in 185 (42.5%), and obstructive CAD in 89 (20.4%).”
High burden of subclinical coronary artery disease in asymptomatic adults with heterozygous familial hypercholesterolemiaAtherosclerosis2026doi:10.1016/j.atherosclerosis.2026.121949
  • Human trial12
  • Humans12
  • In silico1

Effects

2

Cataract

no changein humans1

1 study
  1. Heterozygous familial hypercholesterolemia was not clearly linked with cataract in humans.

    Humanscataract surgery used as proxy for cataract development; HeFH on statins versus relatives without hypercholesterolemia≥5 years statin treatment

More on Cataract

PCSK9

upin humans1

1 study
  1. Heterozygous familial hypercholesterolemia is linked with higher PCSK9 in humans.

    Humansn = 255

More on PCSK9

Associations

4

Coronary artery disease

upin humans1

1 study
  1. Heterozygous familial hypercholesterolemia is associated with coronary artery disease in humans (Non-obstructive CAD: 185 (42.5%); obstructive CAD: 89 (20.4%)).

    HumansAsymptomatic heterozygous familial hypercholesterolemia without prior atherosclerotic cardiovascular diseasecoronary artery56% womensn = 435

More on Coronary artery disease

Cumulative LDL-C burden

upin humans1

1 study
  1. Heterozygous familial hypercholesterolemia is associated with cumulative LDL-C burden in humans (Suspected HeFH versus non-FH participants with identical LDL-C thresholds) (102±37 vs 39.5±21 mmol/L-years; mean difference 62.5 mmol/L-years, 95% CI 42.6–82.4; 2.6-fold higher burden).

    HumansSuspected HeFH versus non-FH participants with identical LDL-C thresholdsn = 16

More on Cumulative LDL-C burden

NRP1

mixedin humans1

1 study
  1. NRP1 is associated with heterozygous familial hypercholesterolemia in humans (depleted samples; HeFH compared with non-FH patients during PCSK9i treatment).

    Humansdepleted samples; HeFH compared with non-FH patients during PCSK9i treatmententire year of treatment

More on NRP1

Diabetes mellitus

downin humans1

1 study
  1. Heterozygous familial hypercholesterolemia is linked with a lower risk of diabetes mellitus in humans (HeFH vs FCH on statin therapy) (2% vs 20%, P < .001).

    HumansHeFH vs FCH on statin therapy10-year follow-upn = 280

More on Diabetes mellitus

Trial sponsors

Latest

Dec 2025: 1Jan 2026: 3Feb 2026: 6Mar 2026: 4Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 4Oct 2026: 9Nov 2026: 1443 papers in 12 months

See all 54 papers on heterozygous familial hypercholesterolemia